Skip to content

Citius Oncology, Inc. CTOR Payment On Expenses Of Placement Agent Fee

Payment On Expenses Of Placement Agent Fee at other companies

JAN
Janus Living JAN
$8.14M
Soluna Holdings, Inc. logo
Soluna Holdings, Inc.SLNH
$0-100%
TPC
TechprecisionTPCS
$34K
JAN
Janus Living JAN
50%
First BanCorp logo
First BanCorpFBP
$191K+19.4%
First BanCorp logo
First BanCorpFBP
$191K+19.4%

Other financials

Income statement

See full
Revenue$1.7M
Gross profit$1.3M
Operating income-$28.6M-283%
Net income-$26.6M-244%
EPS (diluted)-$0.27-145%

Balance sheet

See full
Cash & equivalents$2.6M+2,350,466%
Total equity$35.3M-1.0%
Total assets$100.7M+10.1%

Cash flow

See full
Operating cash flow-$3.8M-179%

Valuation

See full
Market cap$60.45M-74.7%

Returns & leverage

See full
Return on equity-119.9%+46.7pp
Current ratio0.5×+0.1×

Where this comes from

Reported directly by Citius Oncology, Inc. in its filing.

Tagged under the XBRL concept ctor:PaymentOnExpensesOfPlacementAgentFee.

The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Citius Oncology, Inc.'s payment on expenses of placement agent fee.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Citius Oncology, Inc.'s payment on expenses of placement agent fee?
Citius Oncology, Inc. (CTOR) reported payment on expenses of placement agent fee of $125K in Q3 2025.
What does payment on expenses of placement agent fee mean?
Reflects the transaction costs paid to financial intermediaries for facilitating equity or debt offerings. These fees are a necessary cost of capital and impact the net proceeds received from financing activities. High fees relative to the capital raised may indicate inefficient capital raising processes or unfavorable market conditions.